--- title: Drug Discovery description: Transform drug discovery with data solutions. Discover how Biomedion's software simplifies R&D processes in life sciences. --- [![biomedion-logo-2020](https://www.biomedion.com/hs-fs/hubfs/biomedion-logo-2020.png?width=898&height=142&name=biomedion-logo-2020.png)](https://www.biomedion.com/en/?hsLang=en) [![biomedion - connecting the dots in life sciences](https://www.biomedion.com/hs-fs/hubfs/biomedion-logo-2020.png?width=898&height=142&name=biomedion-logo-2020.png) biomedion-logo-2020](https://www.biomedion.com/en/?hsLang=en) ![biomedion - connecting the dots in life sciences](https://www.biomedion.com/hubfs/biomedion-logo-2020.png) - [Products](https://www.biomedion.com/en/) - [Watcher 2.x](https://www.biomedion.com/watcher-2.x-the-proven-classic-for-gxp-compliant-long-term-archiving) - [Professional Services](https://www.biomedion.com/en/biomedion-professional-services) - [Raw Data Archiving](https://www.biomedion.com/en/raw-data-archiving) - [Pharma](https://www.biomedion.com/en/pharma) - [Biotech](https://www.biomedion.com/en/biotech) - [Health Science](https://www.biomedion.com/en/healthscience) - [Business Cases](https://www.biomedion.com/en/business-cases) - [Drug discovery](https://www.biomedion.com/en/drug-discovery) - [Non-Clinical](https://www.biomedion.com/en/non-clinical) - [Company](https://www.biomedion.com/en/company) - [Contact](https://www.biomedion.com/en/contact) Search Site [Connect With Us!](https://www.biomedion.com/en/contact?hsLang=en) BUSINESS CASE # Raw data archiving in Drug Discovery 79 % #### Cups of coffee 543 + #### Cups of coffee 50 bn US$ #### Cups of coffee ## How new medications are discovered Drug discovery is the process how new medications are discovered. In history, drugs were mostly found by identifying active ingredients from traditional medicines or purely by chance. Afterward, classical pharmacology was used to investigate chemical libraries including small molecules, natural products, or plant extracts, and find those with therapeutic effects. Since human DNA was sequenced, reverse pharmacology has found remedies to existing diseases through testing.  Disease processes, molecular compound tests, existing treatments with unanticipated effects, and new technologies spur drug discovery through the cycle below. Today drug discovery involves screening hits, medicinal chemistry, and optimization of hits to reduce potential drug side effects (increasing affinity and selectivity). Efficacy or potency, metabolic stability (half-life), and oral bioavailability are also improved in this step of the drug development process. ###### Solutions ### Cost savings by eliminating manual processes and streamlining data capture **Watcher 4.0** is an advanced technology that provides direct and indirect cost savings by eliminating manual processes and streamlining data capture. By leveraging automated data entry, consisting of rule-based or AI-driven processes, **Watcher 4.0** helps to facilitate greater diversity in both site and patient participation. By integrating **[Watcher 4.0](https://www.biomedion.com/product-page-watcher40?hsLang=en)** into your workflow, you can bridge the data-capture gap and streamline your GxP archiving processes. **Watcher 4.0** offers numerous advantages over manual capture, such as reducing direct and indirect costs associated with meta-data enrichment and source data verification. Plus, it supports greater diversity in both site and patient participation, enabling more comprehensive results. To make the most of this technology and ensure compliance with GxP archiving, we suggest following best practices when implementing **Watcher 4.0** integration across the life cycle. This includes carefully verifying source data, ensuring data integrity and accuracy, and leveraging meta-data enrichment to ensure a complete and accurate record. At biomedion, we understand the importance of data capture and the challenges associated with it. That’s why we’re proud to offer our **Watcher 4.0** to provide a robust solution to our clients. With **Watcher 4.0**, managers can rest assured that their research teams are able to capture, clean, and manage data in a secure, efficient, and compliant manner. Read more about Watcher 4.0 Marketing Marketing Global Marketing Automation Strategy ###### Solutions ### Cost savings by eliminating manual processes and streamlining data capture **Watcher** is an advanced technology that provides direct and indirect cost savings by eliminating manual processes and streamlining data capture. By leveraging automated data entry, consisting of rule-based or AI-driven processes, **Watcher** helps to facilitate greater diversity in both site and patient participation. By integrating **Watcher** into your workflow, you can bridge the data-capture gap and streamline your GxP archiving processes. **Watcher** offers numerous advantages over manual capture, such as reducing direct and indirect costs associated with meta-data enrichment and source data verification. Plus, it supports greater diversity in both site and patient participation, enabling more comprehensive results. To make the most of this technology and ensure compliance with GxP archiving, we suggest following best practices when implementing **Watcher** integration across the life cycle. This includes carefully verifying source data, ensuring data integrity and accuracy, and leveraging meta-data enrichment to ensure a complete and accurate record. At biomedion, we understand the importance of data capture and the challenges associated with it. That’s why we’re proud to offer our **Watcher** to provide a robust solution to our clients. With **Watcher**, managers can rest assured that their research teams are able to capture, clean, and manage data in a secure, efficient, and compliant manner. Learn more about **[Watcher 2.x](https://www.biomedion.com/watcher-2.x-the-proven-classic-for-gxp-compliant-long-term-archiving?hsLang=en)**! Marketing Marketing Global Marketing Automation Strategy > “"The only way to discover the limits of the possible is to go beyond them into the impossible.” Arthur C. Clarke | Futurist Drug Development Trends for 2023 ## AI & Data Analytics Over the past few years, there has been a drastic increase in data digitalization in the pharmaceutical sector. Startups are developing increasingly better tools to acquire, scrutinize, and apply large volumes of data towards bottlenecks in drug development. This drives the use of AI to automate data processing to solve complex clinical problems. The application of AI aids drug discovery, repurposing, side effects prediction, and clinical trials. It also assists in decision-making to determine the right therapy for patients, including personalized medicines. Overall, data-driven intelligent technologies make drug development procedures cost-effective, faster, and more productive. ## More services ### From validation to technical support ![validation](https://f.hubspotusercontent40.net/hubfs/8124098/Images/services-details-prox-page.jpg) #### Computer System Validation We create all documents necessary for the computer system validation for you or together with you. From the validation plan to the validation report. We have been providing this service to our customers for twenty years - our documents have been used in countless audits. **HIGHLIGHTS** - Validation Plan - Risk Analysis - Traceability Matrix - Test Plans - Test Protocols - Test Reports - Much more! Discover our Validation Services ![consulting-service](https://f.hubspotusercontent40.net/hubfs/8124098/Images/prox-consulting-service.jpg) #### Regulatory Operations Services The team at biomedion has extensive and diverse submission experience and is ready to assist with your specific needs. We specialize in the planning, processing and submission of original and lifecycle submissions to Health Authorities. We are submission and eCTD subject matter experts and offer flexible and efficient support for all stages of a regulatory application.  **HIGHLIGHTS** - Original Applications - Lifecycle Applications - Promotional Materials Submission - Submission Planning - Templates and Formatting Services for Regulatory Compliance ![maintenance-service](https://f.hubspotusercontent40.net/hubfs/8124098/Images/services_04.jpeg) #### Technical Consulting We advise you on the use of our solutions, make the necessary configurations for them or develop adaptations, e.g. for the integration of other products. In doing so, we work closely with our colleagues in the computer system validation department. **HIGHLIGHTS** - Configuration - Workflows - System integration - Security - GDPR Our professional Solutions ## Ready to get started? Together we can create something all inspirational you need to build. [Reach out to us](https://www.biomedion.com/en/get-consultation?hsLang=en) [![biomedion-logo](https://26577795.fs1.hubspotusercontent-eu1.net/hubfs/26577795/logos/biomedion-logo-2020.png)](https://www.biomedion.com/?hsLang=en) At biomedion GmbH, we are dedicated to the **secure and GxP-compliant long-term** **archiving of scientific data**. Our strategic focus is on the **"Watcher" product family** as the central brand for GxP-compliant data archiving. [linkedin-in](https://www.linkedin.com/company/biomedion/) [youtube](https://www.youtube.com/channel/UCLRBLZvHFoc5YzgyYiI9Ycw) [podcast](https://daten-doku-digital.podigee.io/) - [Watcher 2.x](https://www.biomedion.com/watcher-2.x-the-proven-classic-for-gxp-compliant-long-term-archiving) - [Services](https://www.biomedion.com/en/biomedion-professional-services) - [Customer Support](https://support.portal.biomedion.com/servicedesk/customer/user/login?destination=portals) - Connect With Us! - [Contact (Company)](https://www.biomedion.com/en/contact) - [Get Consultation](https://www.biomedion.com/en/get-consultation) - [Get a Quote today](https://www.biomedion.com/en/get-a-quote-today) ![667_RGB](https://www.biomedion.com/hs-fs/hubfs/Footer/667_RGB.png?width=140&height=140&name=667_RGB.png) biomedion GmbH is certified according to ISO/IEC 27001:2022 for secure and compliant data management and archiving solutions in highly regulated environments. Certificate Registration No. 44 121 241800; Audit Report No. 35411490   ![ISO_weiss](https://www.biomedion.com/hs-fs/hubfs/ISO_weiss.png?width=150&height=150&name=ISO_weiss.png) biomedion GmbH is certified according to DIN EN ISO 9001:2015 for providing on- premises and cloud-based data archiving solutions and raw-data archiving services. Certificate Registration No. 44 100 241800; Audit Report No. 3538 1557               © 2026 biomedion GmbH - [Privacy Policy](https://www.biomedion.com/en/privacy-statement) - [Imprint](https://www.biomedion.com/en/imprint)